Patents Assigned to MIDWAY PHARMACEUTICALS, INC.
  • MANAGING OSTEOPOROSIS WITH HMW PEG
    Publication number: 20190015353
    Abstract: The present invention relates to the administration of compositions comprising polyethylene glycol, for improving the general gastrointestinal health of an animal increasing growth performance and treating osteopenia, osteoporosis and other bone disorders.
    Type: Application
    Filed: August 10, 2018
    Publication date: January 17, 2019
    Applicants: MIDWAY PHARMACEUTICALS, INC., BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
    Inventors: Rifat PAMUKCU, Laura Rae McCABE
  • Managing osteoporosis with HMW PEG
    Patent number: 10045949
    Abstract: The present invention relates to the administration of compositions comprising polyethylene glycol, for improving the general gastrointestinal health of an animal increasing growth performance and treating osteopenia, osteoporosis and other bone disorders.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 14, 2018
    Assignees: MIDWAY PHARMACEUTICALS, INC, BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
    Inventors: Rifat Pamukcu, Laura Rae McCabe
  • MANAGING OSTEOPOROSIS WITH HMW PEG
    Publication number: 20160000730
    Abstract: The present invention relates to the administration of compositions comprising polyethylene glycol, for improving the general gastrointestinal health of an animal increasing growth performance and treating osteopenia, osteoporosis and other bone disorders.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 7, 2016
    Applicants: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY, MIDWAY PHARMACEUTICALS, INC.
    Inventors: Rifat PAMUKCU, Laura Rae MCCABE